Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-49,040
Closed -$1.79M 125
2022
Q1
$1.79M Buy
49,040
+2,570
+6% +$96.1K 0.75% 39
2021
Q4
$2M Sell
46,470
-810
-2% -$31.3K 0.85% 41
2021
Q3
$1.58M Sell
47,280
-1,830
-4% -$61.1K 0.73% 43
2021
Q2
$1.59M Buy
49,110
+2,540
+5% +$81.4K 0.76% 41
2021
Q1
$1.54M Sell
46,570
-220
-0.5% -$6.63K 0.82% 42
2020
Q4
$1.21M Buy
46,790
+90
+0.2% +$2.1K 0.74% 47
2020
Q3
$905K Buy
46,700
+230
+0.5% +$4.54K 0.61% 49
2020
Q2
$904K Buy
+46,470
New +$794K 0.66% 49

Other funds holding KLAC

Shilanski & Associates's KLAC Position: Q2 2022 in Review

Shilanski & Associates sold out of KLA (KLAC) in Q2 2022, closing a stake of 49,040 shares — an estimated $1.79M sold.

Shilanski & Associates first reported a position in KLAC in Q2 2020 and held it in 8 quarters. The position peaked at $2M in Q4 2021. 1,070 funds tracked by Wall St. Rank hold KLAC as of Q2 2022.

  • Shilanski & Associates reported no remaining KLA position as of Q2 2022 after selling out during the quarter.
  • Shilanski & Associates sold 49,040 KLA shares in Q2 2022, an estimated $1.79M.
  • Shilanski & Associates first reported a position in KLA in Q2 2020 and held it in 8 quarters.
  • Shilanski & Associates's KLA position peaked at $2M in Q4 2021.
  • 1,070 funds tracked by Wall St. Rank held KLA as of Q2 2022.

Based on Shilanski & Associates's 13F filing for Q2 2022, filed 2 Aug 2022.